artesunate brands
84 registered brands containing artesunate in Kenya.
artesunate
PubChem CID 6917864Molecular formula: C19H28O8
Artesunate is metabolized to the active DHA. the endoperoxide bridge of DHA reacts with heme, generating free radicals which inhibit protein and nucleic acid synthesis of the _Plasmodium_ parasites during all erythrocytic stages. Reactions with these free radicals can also lead to alkylation of parasitic proteins such as a calcium adenosine triphosphatase and EXP1, a glutathione S-transferase. Two theories have been put forward for the mode of antimalarial action of the artemisinin antimalarials, in accodance with the known properties of peroxides with medicinal activity. The first assumes that the artemisinins must be activated by contact with either reduced haem (ferrous haem, Fe(ll)PPIX) or non-haem ferrous iron (exogenous iron), causing cleavage of the peroxide to generate oxygen-centered radicals (alkoxy radicals') which are the presumed to be converted into carbon-centered radicals by transfer of proximate hydrogen atoms from the periphery of the peroxide molecule. These carbon-centered radicals are then thought to alkylate sensitive, yet unspecified, biomolecules in the parasite. A second theory argues for a process in which the intact artemisinin binds to a site within a vital protein in the parasite. The act of binding causes the peroxide to be converted to hydroperoxide or similar open peroxide, which in accordance with known properties of such compounds, generates one or more active chemical entities, either oxidizing agents or oxygen transfer agents per se, or oxygen-centered free radicals. This would be associated with the binding process. In such a way, the artemisinins might act as (irreversibile) inhibitors. Iron may, or may not, be associated with the activation process. No specific biological target in the parasite has yet been identified in support of this theory, but it may be membrane-bound proteins. Artesunate is a water soluble derivative of artemisinin, an antimalarial compound isolated from the Chinese herb Qinghao (Artemisia annua). Artesunate is rapidly metabolized to dihydroartemisinin (DHA) in the body. Chemically, artesunate, and its active metabolite, DHA, are sesquiterpene lactones with a trioxane ring containing a peroxide bridge. The peroxide bridge appears to be essential for the antimalarial activity of artesunate. Structure-activity relationship studies show that the deoxy derivative of DHA (that lack the peroxide bridge) was 277-fold less active than DHA. The activity of deoxyartesunate was not measured. Deoxy derivatives of other artemisinin analogs were 10- to 1000-fold less active compared to the parent compounds. Artesunate increases superoxide anion production and lipid peroxidation in falciparum-infected erythrocytes in vitro. However, artesunate does not suppress the activity of antioxidant enzymes (superoxide dismutase, catalase, glutathione reductase, and glutathione peroxidase) in infected or uninfected erythrocytes. Erythrocytes infected with the ring or trophozoite forms in vitro accumulate 100- and 180- fold higher concentrations of DHA (12 nM ie, 3.40 ng/mL), respectively, compared to uninfected erythrocytes. These experiments were performed in a medium containing 10% human serum. The relevance of these findings to the uptake in vivo is unclear. The precise mechanism by which artesunate exhibits antiplasmodial activity is not understood. A 2025 systematic review notes Artesunate's pharmacological activities (antimalarial, antiparasite,antitumor, antivirus, antiinflammation, and antibacterial),and that it is a highly effective antimalarial agent with the potential to induce organ toxicity under certain conditions. The authors note that mechanisms of Artesunate-induced toxicity include oxidative stress, inflammation, and apoptotic signaling patthhways.They also note that Artesunate ameliorates MASH (Metabolic Dysfunction-Associated Steatohepatitis) by reducing inflammation and lipid accumulation by regulating NLRP3 inflammasome and reducing lipid accumulation (SREBP-1c, FAS).
Source: PubChem (NCBI) · compound 6917864
| Product | Manufacturer | Status | Country |
|---|---|---|---|
| AMQUNATE 100/270 TABLETS 100:270MG |
Cosmos | Registered | Kenya |
| AMQUNATE 50/135MG TABLETS 50:135MG |
Cosmos | Registered | Kenya |
| AMQUNATE FORTE TABLETS COMBIPACK 600:200MG |
Cosmos | Registered | Kenya |
| AMQUNATE P 25/76.5 PAEDIATRIC DISPERSIBLE TABLETS 25 / 76.5MG |
Cosmos | Registered | Kenya |
| AMQUNATE TABLETS 50:153MG |
Cosmos | Registered | Kenya |
| APMOD 100/270 ARTESUNATE PH INT...100MG AMODIAQUINE HYRDOCHLORIDE IH EQUIVALENT TO AMODIAQUINE 270MG |
Harleys | Registered | Kenya |
| APMOD 25/67.5 ARTESUNATE PHINT...25MG AMODIAQUINE HYDROCHLORIDE IH EQUIVALENT TO AMODIAQUINE..67.5MG |
Harleys | Registered | Kenya |
| APMOD 50/135 ARTESUNATE PH INT 50MG AMODIAQUINE HYDROCHLORIDE IH EQUIVALENT TO AMODIAQUINE...135MG |
Harleys | Registered | Kenya |
| AQUANATE 60 INJ 60 MG/VIAL |
Syner-med Pharmaceuticalsltd | Registered | Kenya |
| ARENAX 100 MG ARTESUNATE AND 300 MG AMODIAQUINE |
Macnaughton | Registered | Kenya |
| ARGESUN 120MG ARTESUNATE 120MG |
Tridem Pharma | Registered | Kenya |
| ARGESUN 180MG ARTESUNATE 180MG |
Tridem Pharma | Registered | Kenya |
| ARGESUN 30MG ARTESUNATE 30MG |
Tridem Pharma | Registered | Kenya |
| ARGESUN 60MG ARTESUNATE 60MG |
Tridem Pharma | Registered | Kenya |
| ARSUN AQ TABLETS ARTESUNATE 100MG + AMODIAQUINE HCL 300MG PER TABLET |
Dawa | Registered | Kenya |
| ARTECAP EACH SOFT GELATIN CAPSULES CONTAINS ARTESUNATE 100MG |
Universal Corporation | Registered | Kenya |
| ARTECOR IV ARTESUNATE 60MG INJECTION 1ML AMPOULE OF SODIUM BICARBONATE INJECTION 5% W/V 5ML AMPOULE OF SODIUM CHLORIDE INJECTION 0.9% W/V |
Signature Healthcare | Registered | Kenya |
| ARTECOR IV 120MG ARTESUNATE 120 MG |
Signature Healthcare | Registered | Kenya |
| ARTEGEN 60MG INJECTION ARTESUNATE (STERILE) 60 MG |
Goodmed Healthcare | Registered | Kenya |
| ARTELIN 120 ARTESUNATE 120 MG PER VIAL |
Medox Pharmaceuticals | Registered | Kenya |
| ARTELIN 30 ARTESUNATE 30 MG PER VIAL |
Medox Pharmaceuticals | Registered | Kenya |
| ARTELIN 60 ARTESUNATE 60 MG PER VIAL |
Medox Pharmaceuticals | Registered | Kenya |
| ARTEQUIN PAEDIATRIC 50 MG ARTESUNATE 125 MG MEFLOQUINE |
Acino Pharma | - | Kenya |
| ARTEQUIN-300/375 LACTAB MEFLOQUINE HYDROCHLORIDE MICRONIZED 1375000 |
Acino Pharma | - | Kenya |
| ARTEQUIN-600/750 LACTAB ARTESUNATE 200 MG MEFLOQUINE 250 MG |
Laborex Kenya | Registered | Kenya |
| ARTESUN ARTESUNATE 120MG |
Tridem Pharma | Registered | Kenya |
| ARTESUN ARTESUNATE 60MG |
Tridem Pharma | Registered | Kenya |
| ARTESUN ARTESUNATE 30MG |
Tridem Pharma | Registered | Kenya |
| Artesun Powder And Solvent For Solution For Injection |
Guilin Pharmaceutical Co. Ltd | Retained | Kenya |
| Artesun Powder And Solvent For Solution For Infusion |
Guilin Pharmaceutical Co. Ltd | Retained | Kenya |
| Artesun Powder And Solvent For Solution For Injection |
Guilin Pharmaceutical Co. Ltd | Retained | Kenya |
| Artesun 120mg Powder And Solvent For Solution For Injection |
Guilin Pharmaceutical Co. Ltd | Retained | Kenya |
| Artesun 30mg Powder And Solvent For Solution For Infusion |
Guilin Pharmaceutical Co. Ltd | Retained | Kenya |
| ARTESUN-PLUS ARTESUNATE 100MG & AMODIAQUINE 270MG (IN THE FORM OF AMODIAQUINE HYDROCHLORIDE: 352.64MG) |
Tridem Pharma | Registered | Kenya |
| ARTESUN-PLUS ARTESUNATE 50MG & AMODIAQUINE 135MG (IN THE FORM OF AMODIAQUINE HYDROCHLORIDE: 176.32MG) |
Tridem Pharma | Registered | Kenya |
| ARTESUN-PLUS ARTESUNATE 25MG & AMODIAQUINE 67.5MG (IN THE FORM OF AMODIAQUINE HYDROCHLORIDE: 88.16MG) |
Tridem Pharma | Registered | Kenya |
| ARTESUNATE AMODIAQUINE BILAYER TABLETS 100MG/270MG ARTESUNATE 100MG, AMODIAQUINE HYDROCHLORIDE 270MG |
Micro Labs | Registered | Kenya |
| ARTESUNATE AMODIAQUINE BILAYER TABLETS 25MG/67.5MG ARTESUNATE 25MG, AMODIAQUINE HYDROCHLORIDE 67.5MG |
Micro Labs | Registered | Kenya |
| ARTESUNATE AMODIAQUINE BILAYER TABLETS 50MG/135MG ARTESUNATE 50MG, AMODIAQUINE HYDROCHLORIDE 135MG |
Micro Labs | Registered | Kenya |
| ARTESUNATE AMODIAQUINE WINTHROP 100MG/270MG TABLET ARTESUNATE 100MG + AMODIAQUINE 270MG |
Ressourcethica | Registered | Kenya |
| ARTESUNATE AMODIAQUINE WINTHROP 25MG/67.5MG TABLET ARTESUNATE 25MG + AMODIAQUINE 67.5MG |
Ressourcethica | Registered | Kenya |
| ARTESUNATE AMODIAQUINE WINTHROP 50MG/135MG TABLET ARTESUNATE 50MG + AMODIAQUINE 135MG |
Ressourcethica | Registered | Kenya |
| ARTESUNATE AND AMODIAQUINE TABLETS ( 50MG+ 135MG) ARTESUNATE PH.INT.50MG AMODIAQUINE HYDROCHLORIDE USP EQUIVALENT TO AMODIAQUINE BASE135MG. |
Sai Pharmaceuticals | Registered | Kenya |
| ARTESUNATE AND AMODIAQUINE TABLETS ( 50MG+ 135MG) ARTESUNATE PH.INT.50MG AMODIAQUINE HYDROCHLORIDE USP EQUIVALENT TO AMODIAQUINE BASE135MG. |
Sai Pharmaceuticals | Registered | Kenya |
| ARTESUNATE AND AMODIAQUINE TABLETS (100MG + 270MG) ARTESUNATE PH.INT 100MG AMODIAQUINE HYDROCHLORIDE USP EQUIVALENT TO AMODIAQUINE BASE.270MG. |
Sai Pharmaceuticals | Registered | Kenya |
| ARTESUNATE AND AMODIAQUINE TABLETS (100MG + 270MG) ARTESUNATE PH.INT 100MG AMODIAQUINE HYDROCHLORIDE USP EQUIVALENT TO AMODIAQUINE BASE.270MG. |
Sai Pharmaceuticals | Registered | Kenya |
| ARTESUNATE AND AMODIAQUINE TABLETS (25MG+67.5MG) EACH BILAYER TABLET CONTAINS ARTESUNATE PH.INT_.25MG AMODIAQUINE HYDROCHLORIDE USP EQUIVALENT TO AMODIAQUINE BASE_..67.5MG. |
Sai Pharmaceuticals | Registered | Kenya |
| ARTESUNATE AND AMODIAQUINE TABLETS (25MG+67.5MG) EACH BILAYER TABLET CONTAINS ARTESUNATE PH.INT_.25MG AMODIAQUINE HYDROCHLORIDE USP EQUIVALENT TO AMODIAQUINE BASE_..67.5MG. |
Sai Pharmaceuticals | Registered | Kenya |
| ARTESUNATE SUPPOSITORIES 100MG 100 MG |
Phillips Healthcare | Registered | Kenya |
| Artesunate Suppositories 100mg Rectal Capsule |
Cipla Limited | Retained | Kenya |